Updated:17 May 2013 03:40:00 PM(IST)
Sensex20286.12
38.79 0.19%
Nifty6187.30
17.40 0.28%
Midcap6613.98
21.77 0.33%
Smallcap6199.19
8.25 0.13%
Cipla Ltd :
ISIN: INE059A01026 | NSE: CIPLA | Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln | BSE Code: 500087 | Comments
| Price Information | |
| • Open | 423.50 |
| • High | 428.00 |
| • Low | 415.90 |
| • Previous Close | 422.25 |
| • Shares Traded | 212068 |
| • 52 Wk High Price | 435.00 |
| • 52 Wk High Date | 09-01-2013 |
| • 52 Wk Low Price | 300.70 |
| • 52 Wk Low Date | 12-06-2012 |
| • Face Value | 2.00 |
| Fundamentals | |
| • Market Capital (Rs.cr) | 33902.40 |
| • EPS (Rs.)(TTM) | 19.43 |
| • P/E Ratio(TTM) | 21.72 |
| • Book Value (Rs.) | 93.90 |
| • Price to Book Value | 4.49 |
| • Equity (Rs.cr.) | 160.58 |
| • Traded Value (Rs.lac) | 1747.87 |
| Corporate Actions | |
| Ex-Date | Purpose (Rs.) |
| 2011-08-09 | 100% Final Dividend (2) |
| 2012-08-01 | 100% Dividend (2) |
| Index Names | |
| • BSE-100 | |
| • BSE-200 | |
| • BSE-500 | |
| • BSE HC | |
| • BSE Sensex | |
| • S&P CNX Nifty | |
| Related Companies | ||
| Stock Name | Price | |
| JBCHEPHARM | 83.40 | |
| JAYANTVITAMINS | 3.00 | - |
| MERIND | 200.00 | - |
| PIRHEALTH | 581.70 | |
| RANBAXY | 471.45 | |
| UNICHEMLAB | 178.00 | |
| ALEMBICLTD | 20.40 | |
| LYKALABS | 9.40 | |
| TTKHEALTH | 514.45 | |
| DRREDDY | 2077.65 | |
| Share Tips for Cipla Ltd |
| buy cipla : Buy cipla above 428, tgt 4 (01:07PM, May 17 '13) |
| Market outlook : Bullish on early hour (08:47AM, May 17 '13) |
| Intraday trading calls : Open=flat. The (09:02AM, May 16 '13) |
| Sell CIPLA For Target 390. : Intraday (02:26PM, May 09 '13) |
| Commodity Stock Tips Free Trial >> Vis (09:23AM, May 09 '13) |
| Key Financials | Latest Qrtr. | Trailing Yr. | Full Yr. |
| • Year End | Dec, 2012 | Dec, 2012 | Mar, 2012 |
| • Sales (Rs.cr) | 2030.70 | 8077.82 | 6977.50 |
| • Net Profit (Rs.cr) | 338.78 | 1559.99 | 1152.66 |
| • Net Profit Var (%) | 26.00 | 50.00 | 20.00 |
| • EPS (Rs) | - | 19.43 | 14.00 |
| • P/E Ratio | - | 21.72 | 30.20 |
| • Operating Profit Margin | - | 26.55 | - |
| • CPS (Rs.) | - | - | 17.50 |
| • P/C Ratio | - | - | 24.10 |
| • Div% | - | - | 100.00 |
| Announcements | |
| 10-12-2010 | Amar Lulla ceases as joint managing director of Cipla |
| 15-11-2011 | Cipla appoints additional director |
| 22-11-2012 | Cipla appoints Subhanu Saxena as CEO |
| 21-02-2011 | Cipla get tentative approval for Abacavir Sulphate |
| 23-04-2011 | Cipla gets tentative approval for the Rizatriptan Benzonate |
| 10-04-2013 | Cipla grants stock options |
| 08-06-2012 | Cipla recommends dividend |
| 28-07-2011 | Cipla to announce Q1 results |
| 03-11-2010 | Cipla to announce Q2 results |
| 03-02-2012 | Cipla to announce Q3 results |
Gross Deliverables
Date
Del. Shares
Trd. Qty.
Del.(%)
Del. Value
Turnover
17-05-2013
57387
212068
27.06
24369390
89829.50
13-05-2013
45531
123212
36.95
17991575
49069.70
11-05-2013
4677
11435
40.90
1880856
4593.32
10-05-2013
47086
130125
36.19
18714331
51585.90
03-05-2013
47475
117943
40.25
19051718
47685.60
Note:
- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, %
change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date &
not adjusted with corporate action
Comment(s) posted on Cipla Ltd
©2011 Appuonline.com